Mesenchymal stem cell research
Mesenchymal stem cell research is a research topic within Genetics. Science Explorer counts 43k research works in it since 1950. 24.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the research and applications of multipotent mesenchymal stem cells, particularly in the areas of regeneration, immunomodulation, therapeutic interventions, differentiation potential, isolation techniques, transplantation procedures, and their role in cardiac repair. The papers cover a wide range of topics related to the properties and potential uses of mesenchymal stem cells in various medical contexts.
- Mesenchymal Stem Cells
- Multipotent
- Regeneration
- Immunomodulation
- Therapeutic
- Differentiation
- Isolation
- Transplantation
- Cardiac Repair
- Stromal Cells
- Research works
- 43k fractional, since 1950
- In the world top 10%
- 10k per year above
- Top-10% rate
- 24.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +1% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Mesenchymal stem cell research research?
By volume, China and the United States publish the most (2.1k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 China 2.1k works
- 2 United States 1.1k works
- 3 Japan 369 works
- 4 Iran 354 works
- 5 India 279 works
- 6 South Korea 254 works
- 7 Italy 233 works
- 8 Germany 204 works
- 9 Brazil 182 works
- 10 Russia 170 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Mesenchymal stem cell research research?
By volume in 2022–2025, Sichuan University publishes the most Mesenchymal stem cell research research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Stomatology Hospital.
By volume, 2022–2025
- 1 Sichuan UniversityChina 48 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 42 works
- 3 Stomatology HospitalChina 34 works
- 4 Chinese PLA General HospitalChina 34 works
- 5 Sun Yat-sen UniversityChina 32 works
- 6 Southern Medical UniversityChina 31 works
- 7 Tehran University of Medical SciencesIran 29 works
- 8 Shanghai Jiao Tong UniversityChina 26 works
- 9 Shahid Beheshti University of Medical SciencesIran 25 works
- 10 Zhejiang UniversityChina 23 works
Who are the leading researchers in Mesenchymal stem cell research?
The most-cited researchers publishing on Mesenchymal stem cell research include Manoj M. Lalu, Giuseppe Remuzzi and Darwin J. Prockop.
- 1 Manoj M. Lalu Canada 13k citations
- 2 Giuseppe Remuzzi Italy 8.1k citations
- 3 Darwin J. Prockop United States 3.8k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Mesenchymal stem cell research research done?
The largest centres of Mesenchymal stem cell research research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Tehran (Iran).
Where is the best place to study Mesenchymal stem cell research?
Among universities, judged by research, Shahid Beheshti University of Medical Sciences, Tabriz University of Medical Sciences and Zunyi Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Shahid Beheshti University of Medical SciencesIran | 71.4 | 29.2% | 10.1× | 25 | +196.1% |
| 2 | Tabriz University of Medical SciencesIran | 69.2 | 29.5% | 12.0× | 19 | +1105.9% |
| 3 | Zunyi Medical UniversityChina | 68.8 | 38.0% | 13.9× | 15 | +182.5% |
| 4 | Southern Medical UniversityChina | 65.1 | 35.3% | 12.1× | 31 | +2.1% |
| 5 | Iran University of Medical SciencesIran | 64.5 | 29.6% | 8.8× | 17 | +505.9% |
| 6 | Sichuan UniversityChina | 61.7 | 42.8% | 3.9× | 48 | +54.5% |
| 7 | Shiraz University of Medical SciencesIran | 60.3 | 22.5% | 10.1× | 19 | +134.2% |
| 8 | Tehran University of Medical SciencesIran | 59.5 | 24.3% | 8.7× | 28 | +74.7% |
| 9 | Air Force Medical UniversityChina | 57.8 | 35.7% | 16.6× | 20 | -34.3% |
| 10 | Mashhad University of Medical SciencesIran | 55.5 | 42.3% | 7.3× | 12 | +54.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Mesenchymal stem cell research research growing?
Output in 2018–2022 was 1% higher than in 2013–2017, peaking in 2014. The fastest-growing topics are Mesenchymal stem cell research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.